NCT04789707|Terminated
Study Stopped
recruitment difficulties
Influence of Keratoconus on Stress at Work
KERATOSTRESS
Loading search results
recruitment difficulties
KERATOSTRESS
Sponsor study identifier
Secondary identifiers
OTHER · 2018-A02527-48
observational
22
1 country
1
Study Start
May 4, 2021
Actual (reported)Primary Completion
May 5, 2023
Actual (reported)Study Completion
May 5, 2023
Actual (reported)Keratoconus is a progressive disorder in which central and paracentral corneal stromal thinning occurs. No studies evaluated the influence of keratoconus on stress at work, nor the influence of treatments of keratoconus on stress at work, including Quality of Life at work and on perception of work. Moreover, it has been shown that some pathologies had greater influence in some occupations, also depending on other characteristics of individuals such as age, sex or socio professional groups. Therefore, we hypothesized that keratoconus 1) will influence stress at work including QoL at work and perception of work, 2) will have a greater influence in some occupations and depending on age, sex, or stage of keratoconus, 3) will induce stoppage of work and occupational reclassifications.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 5, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 3, 2021
Actual (reported)March 9, 2021
Actual (reported)May 4, 2021
Actual (reported)May 5, 2023
Actual (reported)May 5, 2023
Actual (reported)stress at work
measured by Job Content questionnaire of Karasek
day 0
psychological consequences
Day 0
Stoppage of work
Day 0
Duration of stoppage of work
Day 0
characteristics of the patient
day 0
Measure of visual acuity.
Day 0
All workers with keratoconus all stages followed at the service of ophthalmology in CHU Gabriel Montpied, Clermont-Ferrand, Auvergne. The investigators only assessed data from usual routine practice. Patients answer the auto questionnaire in last minutes of consultation.
workers with good visual acuity consulting in ophthalmology service of Clermont-Ferrand. The investigators only assessed data from usual routine practice. Patients answer the auto questionnaire in last minutes of consultation.
Patients answer the auto questionnaire in last minutes of consultation.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
patients with keratoconus patients constituting a representative control group of workers consulting in ophthalmology service of Clermont-Ferrand.
CHU - Gabriel Montpied
Clermont-Ferrand, 63000, France
Frédéric DUTHEIL
University Hospital, Clermont-Ferrand
22 participants (actual enrollment reported by the registry).
First Submitted
March 3, 2021
First Posted
March 9, 2021
Study Start
May 4, 2021
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
May 5, 2023
Actual (reported)Study Completion
May 5, 2023
Actual (reported)Last Updated
October 19, 2023
Record last verified: 2023-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: